Pfizer Ltd – COX-2-Inhibitor

ANIMA RES produziert für PFIZER eine 16-minütigen Mode of Action 3D Computeranimation in HD-Auflösung. Die verschiedenen Kapitel des Films beschäftigen sich, im Kontext des Gastrointestinaltrakts, mit der Entstehung und Diagnose von Magengeschwüren, sowie dem Einsatz von sog. NSAIDs, NSAIDs+PPI und COX-2-Inhibitoren.

Der selektive Cyclooxygenase 2 (COX-2) Inhibitor hemmt überwiegend die für Schmerzen und Schwellung zuständigen COX-2, während der u.a. den Magenschutz regulierende COX-1, nur gering gehemmt wird.

 

Testimonial:
„Pfizer is a research driven Global Health Care company. For one of our brands we were specifically faced with the challenge of communicating a drug pathway, potential side effects and outcomes thereof in a visually stimulating way. The animation had to meet the needs of both a variety of customers as well as be relevant on a regional and a local level. We worked with ANIMA RES to create this animation. It has been a pleasure to work with ANIMA RES throughout this project and I was very grateful for the innovative input as well as large degree of flexibility demonstrated by ANIMA RES. The animation has now been translated into all major languages across our region and is being used either fully or in part (different chapters were created) extensively both on a local and on a regional level. I would be glad to work with ANIMA RES again and would recommend this company.“

Mark Haberland, Regional Brand Manager CNS/Pain, Worldwide Pharmaceutical Operations, Pfizer Ltd.